Patents
Patents for C07C 233 - Carboxylic acid amides (28,881)
06/2008
06/18/2008EP1513803B1 Ligands that are inhibitors of the rar receptors
06/18/2008CN101200620A Curable hybrid electron donor compounds containing vinyl ether
06/18/2008CN101200450A 2,6-quinolinyl and 2,6-naphthyl derivatives, processes for preparing them and their uses as vla-4 inhibitors
06/18/2008CN101200435A Method for preparing tamibaroteneó� crystal
06/18/2008CN101200434A Preparation method for (Z)-7-chloro-((S)-2,2-dimethylcyclopropanecarboxamido)-2-heptenoic acid
06/18/2008CN101200433A Method for preparing high-purity capsaicin monomer
06/18/2008CN100395231C Process for the synthesis of 6-amino-4-(3-chloro-4-fluoro-phenylamino)-7-ethoxy-quinoline-3-carbonitrile
06/17/2008US7388118 Amine 1,2- and 1,3-diol compounds
06/17/2008US7388111 Non-nucleoside reverse transcriptase inhibitors
06/17/2008CA2347882C Production of amides and/or acids from nitriles
06/17/2008CA2286772C Fungicide active substance combinations
06/17/2008CA2284468C Anti-inflammatory compounds
06/12/2008WO2008070111A2 Processes for preparing (r)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1h-3-benzazepine and intermediates thereof
06/12/2008WO2008069813A1 Photosensitive polyimides and methods of making the same
06/12/2008WO2008069812A1 Photosensitive polybenzoxazines and methods of making the same
06/12/2008WO2008068064A1 Integrated process and apparatus for preparing esters of methacrylic acid from acetone and hydrocyanic acid
06/12/2008WO2008067713A1 Compounds having substituted cyclopentane structure, their preparation methods and medical uses
06/12/2008WO2007127639A3 Prodrug derivatives of acids using alcohols with homotopic hydroxy groups and methods for their preparation and use
06/12/2008US20080139846 Preparing 4,4-difluorocyclohexane carboxylic acid amide derivatives by reacting 1-(aminomethyl)-4,4-difluorocyclohexane with reducing agent in solvent; chlorination, amination, amidation
06/12/2008US20080139636 Adamantane derivatives
06/12/2008US20080139630 Tissue-selective androgen receptor modulators (SARMs); male hypogonadism, prostate cancer, benign prostate hyperplasia, sarcopenia, rheumatoid arthritis and osteoarthritis; N-((5-cyclopropyl-2-fluoropyridin-3-yl)methyl)-2-phenylbutanamide for example
06/12/2008CA2670285A1 Processes for preparing (r)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1h-3-benzazepine and intermediates thereof
06/11/2008CN101198583A Compounds which inhibit beta-secretase activity and methods of use
06/11/2008CN101195612A Compound with substituted cyclobutane structure, production method and medicine use thereof
06/11/2008CN101194901A Use of agomelatine to obtain medication aimed at treating Smith-Magenis syndrome
06/10/2008US7385080 Method for producing optically active β-phenylalanine compounds
06/10/2008US7385063 Method for preparing imidazole derivatives
06/10/2008US7384979 Substituted amino acids as erythropoietin mimetics
06/10/2008CA2371827C Amide compounds for the potentiation of cholinergic activity
06/05/2008WO2008066900A1 1,4 diamino bicyclic retigabine analogues as potassium channel modulators
06/05/2008WO2008064432A1 Polycyclic molecular compounds
06/05/2008US20080132719 preparing the enantiomerically pure carboxylic acid derivatives ethyl (1R,2R)-trans2-(3,4-difluorophenyl)cyclopropyl carboxylate; as starting material for trans2-(3,4-difluorophenyl)cyclopropyl carboxamide; chemical intermediates for producing platelet receptor antagonists, anticoagulants
06/05/2008US20080132706 Compounds as PDE IV and TNF Inhibitors
06/05/2008US20080132578 venlafaxine metabolites used for treating and preventing psychological disorders, Parkinson's disease, epilepsy, obesity, incontinence or Alzheimer's disease; side effect reduction
06/05/2008US20080132574 Leukotriene B4 receptor binding activity; treatment of skin disease such as psoriasis, eczema, skin cancer, keratosis, dyspigmentation or psilosis
06/05/2008US20080132459 Inhibitors of Histone Deacetylase
06/05/2008CA2670966A1 1,4 diamino bicyclic retigabine analogues as potassium channel modulators
06/04/2008EP1927587A2 Conjugated dienamides, methods of production thereof, compositions containing same and uses thereof
06/04/2008CN101193895A Process for producing tricyclic ketone
06/04/2008CN101190896A Method for preparing naphthenic acid imidazolines and betaine of amide thereof, and application of the same in HCl-H2S-H2O system
06/04/2008CN101190887A Synthesis of pharmaceutical
06/04/2008CN101190886A Method for synthesizing N-acylphenylglycine by amide carbonylation reaction
06/03/2008US7381840 2-Hydroxy-1,2,3,4-tetrahydronaphthalenes substituted in the 8-position with a biphenylcarbonylamino-, biphenylcarbonylaminoalkyl-, biphenylaminocarbonylamino-, or biphenylaminocarbonylaminoalkyl- group; vanilloid receptor antagonists
06/03/2008US7381832 Polyhalogen-substituted cinnamic acids and cinnamic acid derivatives and a process for the preparation of polyhalogen-substituted cinnamic acids and cinnamic acid derivatives
06/03/2008US7381734 Serine protease inhibitors
06/03/2008CA2334579C Secondary aspartic acid amide esters
05/2008
05/29/2008WO2008064320A2 Hydrindane analogs having sphingosine 1-phosphate receptor agonist activity
05/29/2008WO2008062859A1 Process for production of phenylalanine derivatives having quinazolinedione skeletons and intermediates for the production
05/29/2008WO2008062044A1 2-hydroxy-1,3-diaminopropane derivatives
05/29/2008WO2008061866A1 New benzamide derivatives
05/29/2008US20080125601 Key steps in the synthesis are early introduction of the correct absolute stereochemistry at C-3 (R) and subsequent regioselective chain lengthening; Unlike the linear synthesis processes in the prior art, the use of the novel statin side chain building blocks allows a convergent synthesis
05/29/2008US20080125491 screening for neuroprotectants such as -Isobutyryl-1,4-a-dimethyl-1,2,3,4,4a,9,10,10a-octahydro-phenanthrene-1-carboxylic acid amide, used for the prevention of neurodegenerative diseases and cardiovascular disorders
05/29/2008US20080125468 Glucagon Receptor Antagonists, Preparation and Therapeutic Uses
05/29/2008US20080125465 Ketone ligands for modulating the expression of exogenous genes via an ecdysone receptor complex
05/29/2008US20080125350 Branched polyalkylene glycols
05/29/2008US20080124285 Merocyanine Derivatives for Cosmetic Use
05/29/2008DE102006055856A1 Production of fatty acid alkanolamide for use, e.g. in emulsifers, lubricants or pharmaceuticals, involves reacting alkanolamine with fatty acid and then subjecting the ammonium salt to microwave radiation
05/29/2008CA2669839A1 2-hydroxy-1,3-diaminopropane derivatives
05/29/2008CA2669104A1 Hydrindane analogs having sphingosine 1-phosphate receptor agonist activity
05/28/2008EP1924553A1 Bicyclo[2.2.]hept-7-ylamine derivatives and their uses
05/28/2008EP1924550A1 Amide forming chemical ligation
05/28/2008EP1768954A4 2-methylpropanamides and their use as pharmaceuticals
05/28/2008CN101186587A Method for synthesizing derivative of beta-amino acid and intermediate product thereof
05/28/2008CN101186585A Method for preparing N-hydroxymethylacrylamide water solution with low formaldehyde content
05/28/2008CN101186549A Method for preparing amino acid by reducing ketoxime acid ester
05/28/2008CN100390135C Novel derivatives of dicarboxylic acid having pharmaceutical properties
05/27/2008US7378551 gelling agent having a high ability of gelling an oily base which is capable of giving a gel composition having a strong gel strength and a good transparency, a gel composition having a strong gel strength and a good transparency, an external composition having a good feel upon use, a cosmetic
05/27/2008US7378448 Diphenylether amide derivatives as opioid receptor antagonists
05/22/2008WO2008059128A1 Phenylic derivatives and use thereof as drugs
05/22/2008US20080119670 Reacting a benzaldehyde derivative with isopropyl magnesium chloride to form an phenylisobutylalchol derivative, treating with sufuric acid and chloroacetonitrile to effect ritter reaction; deprotection, coupling, hydrolysis
05/22/2008US20080119556 Geranly compounds
05/22/2008US20080119526 Ep2 receptor agonists
05/21/2008EP1923391A1 Substituted heterocyclic compounds, method for preparing same and pharmaceutical compositions containing them.
05/21/2008EP1362027B1 Acylated 6,7,8,9-tetrahydro-5h-benzocycloheptenyl amines and their use as pharmaceutical
05/21/2008CN101184734A Compositions and methods of treating cell proliferation disorders
05/21/2008CN101184726A 2-arylpropionic acid derivatives and pharmaceutical compositions containing them
05/21/2008CN101184725A N-alkylcarbonyl-amino acid ester and n-alkylcarbonyl-amino lactone compounds and their use
05/21/2008CN101184470A Cooling compounds
05/21/2008CN101182372A Weather-resistant polycarbonate containing N,N'-oxalyl diphenylamine structure unit, manufacturing method therefore and products made thereby
05/21/2008CN101182298A Compound 2-hydroxy-5-butyrylamino benzoic acid and uses thereof
05/20/2008US7375241 use of the metal complexes as catalysts for enantioselective addition reactions with prochiral organic compounds
05/20/2008US7375093 Nuclear receptor-based inducible gene expression system
05/20/2008US7374749 Amino substituted hydroxyphenyl benzophenone derivatives
05/20/2008CA2473759C Antibodies for detecting ecstasy-class analytes
05/20/2008CA2419698C Compounds, antibodies, reagent kits, methods of producing antibodies, and methods of detecting analytes
05/20/2008CA2395717C Fused imidazolium derivatives
05/20/2008CA2169695C Substituted benzenesulfonylureas and -thioureas, processes for their preparation, their use for the production of pharmaceutical preparations and medicaments containing them
05/20/2008CA2169694C Substituted benzenesulfonylureas and -thioureas, processes for their preparation, their use as a medicament or diagnostic, and medicament containing them
05/15/2008WO2008056119A1 N-alkylcarbonyl-d-amino hydroxyalkyl ester compounds and their use
05/15/2008WO2008056118A1 N-aryl-hydroxyalkylidene-carboxamide compounds and their use
05/15/2008WO2007034254A8 Amino-alkyl-amide derivatives as ccr3 receptor ligands
05/15/2008US20080114187 Formoterol tartrate process and polymorph
05/15/2008US20080114179 Process and intermediates for the preparation of (1R,2S,5S)-6,6-dimethyl-3-azabicyclo[3,1,0]hexane-2-carboxylates for salts thereof
05/15/2008US20080114062 N-(2-hydroxy-1-methyl-ethyl)-3-iodobenzamide; for the treatment of a muscular disorder, a gastrointestinal disorder, or for controlling spasticity or tremors; modulates cannabinoid receptors
05/15/2008US20080114061 Diphenylethylene compounds and uses thereof
05/15/2008US20080113989 For example, N-(1-Carbamoyl-1-oxo-3-phenylpropan-2-yl)-2-(E-2-(4-(1-pyrrolidinylmethyl)phenyl)ethen-1-yl)benzamide; calcium channel blockers; cardiovascular disorders; antiarthritic agents; inhibitors of enzymes, especially cysteine proteases such as calpain and cathepsins
05/15/2008US20080113939 N-geranylgalacturonamide; anticarcinogenic, antitumor agent
05/15/2008US20080113172 Partially fluorinated compositions and surface active agents
05/15/2008US20080112899 Carboxamides and Their Use
05/15/2008DE19753655B4 α-Aminoacetophenonverbindungen, Massen, die diese Verbindungen enthalten und deren Verwendung als Photostarter α-Aminoacetophenonverbindungen, compositions containing these compounds and their use as photoinitiators
1 ... 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 ... 289